Product Information

CARVEDILOL 3.125 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0168 per EA under NDC 65862014205. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARVEDILOL 3.125 MG TABLET

Carvedilol
$0.0168per EA

Strength

3.125 mg/1

NDC

65862014205

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARVEDILOL

Approval Type

Generic (ANDA)

FDA Application

ANDA078332

FDA Approved

9/5/2007

TE Code

AB

On Market Since

9/5/2007

Pharmacological Classes

Adrenergic alpha-Antagonists
Adrenergic beta1-Antagonists
Adrenergic beta2-Antagonists
alpha-Adrenergic Blocker
beta-Adrenergic Blocker

Price Statistics

The NADAC for CARVEDILOL 3.125 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 52.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0168 per EA
All-time high$0.0370 (Mar 12, 2014)
All-time low$0.0133 (Nov 20, 2024)
52-week high$0.0174
52-week low$0.0163
Median price$0.0231
Average price$0.0239
Largest weekly change-22.2% (Nov 20, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+0.2%

1M

+0.2%

3M

-3.8%

6M

-0.6%

1Y

+0.1%

3Y

-4.3%

5Y

-27.3%

All

-52.8%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CARVEDILOL 3.125 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 3.125 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0168 per EA (NDC 65862014205), effective Aug 19, 2026.

How has the price of CARVEDILOL 3.125 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARVEDILOL 3.125 MG TABLET has declined 52.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CARVEDILOL 3.125 MG TABLET?

Since Nov 28, 2013, the NADAC for CARVEDILOL 3.125 MG TABLET has ranged from a low of $0.0133 (Nov 20, 2024) to a high of $0.0370 (Mar 12, 2014), with a median of $0.0231 per EA.

Are there cheaper alternatives to CARVEDILOL 3.125 MG TABLET?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARVEDILOL 3.125 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CARVEDILOL 3.125 MG TABLET?

CARVEDILOL 3.125 MG TABLET (NDC 65862014205) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.